JHS Svendgaard Laboratories Limited (NSE: JHS)

Market Cap	2.34B
Revenue (ttm)	836.07M
Net Income (ttm)	-20.98M
Shares Out	85.60M
EPS (ttm)	-0.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	229,067
Open	29.00
Previous Close	28.79
Day's Range	27.45 - 29.48
52-Week Range	15.55 - 39.50
Beta	0.74
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2024

About JHS

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades, and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture tablet products under the Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, Amway, Dabur, Future Group, Apollo Pharmacy, Sandika Pharma, Elder Pharma, JL Morisons, Aquawhite, 6 Ten Store, Modi Care, Infectiguard, and Odonil bra...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1997
• Employees: 250
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: JHS

Financial Performance

In 2023, JHS's revenue was 728.93 million, a decrease of -20.04% compared to the previous year's 911.59 million. Losses were -154.64 million, 281.6% more than in 2022.